Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - observed in clinical trials completed to date, such as infections, increases in cholesterol levels, and liver
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - potency could potentially increase frequency of important adverse events such as rhabdomyolysis and liver
  3. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - NSAIDs have increased risk of serious gastrointestinal, liver dysfunction, and cardiovascular adverse
  4. effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - observed in clinical trials completed to date, such as infections, increases in cholesterol levels, and liver
  5. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - relaying new safety information to health care professionals and patients about rare cases of severe liver
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, and liver
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
    June 05, 2013 - I would consider fatty liver disease, metabolic syndrome, etc. conditions that would fall under 'metabolic
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
    December 20, 2012 - clinically relevant, and highlight the need for research in final health outcomes, particularly clinical liver
  9. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - this caveat about the demand for donor lungs: “[It] is much lower than the demand for kidneys and livers
  10. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - or more aggressive in those with one treatment than another (i.e., surveillance bias, e.g., when liver
  11. effectivehealthcare.ahrq.gov/health-topics/period-pain
  12. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
    October 01, 2010 - CF patients on rhGH rarely experienced a transient increase in liver transaminases in two single- arm
  13. effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - lymphocyte counts, diarrhea, flushing, gastrointestinal symptoms, headache, and a mild increase in liver … events associated with dimethyl fumarate included “diarrhea, decreased lymphocyte counts, elevated liver
  14. effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
    November 03, 2020 - /opioids-older-adults/report Published Online: November 3, 2020 81 cause further damage to my liver … after having a negative reaction to synthetic chemicals of other pain medications, without harming my liver
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
    January 01, 2014 - trial specified that the researchers looked for toxicities of meditation to hematologic, renal, and liver
  16. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - hyperglycemia and blocks the effects of glucagon, a hormone produced in the pancreas that signals the liver
  17. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
    January 01, 2012 - consistently maintained, using an insulin-only system or a bi-hormonal system that mimics normal liver
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
    January 01, 2016 - CT Cohort studies: 1 (55) Accuracy in detecting liver IH Insufficient Ultrasound detected lesions
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
    January 01, 2018 - 15: As for adverse events, the description should include low blood pressure (alpha-2 agonists) and liver
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - patients with psychiatric or other serious comorbid conditions, including patients 10 with renal or liver

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: